Oncology - BAUS I-DUNC Audit
Data submission has been extended to 14 May 2024
Data submission is underway for the Impact of Diagnostic Ureteroscopy on Radical Nephroureterectomy and Compliance with Standard Care (I-DUNC) audit.
Thank you to all the units who have already submitted their data - check the list to see if your unit has already submitted!
The link to the JotForm data submission platform has been sent to all Clinical Audit Leads for Urology.
You can see more information about the I-DUNC audit here (members' log in is required)
Oncology - Studies of Malignant Ureteric Obstruction
The BAUS Oncology Section would like to make members aware of the opportunity to participate in two linked studies of patients with Malignant Ureteric Obstruction (MUO):
INSITE MUO launching in May 2024, and seeks to determine the incidence of MUO in patients with abdominopelvic malignancies, along with their initial management.
OPTIMISE MUO is planned to launch in the Autumn, and will prospectively assess the rationale for intervention, and whether that is ultimately realised, along with reviewing differences in outcome by management approach.
Thanks to the units who have already signed up - click here for more info about both studies and to register your interest.
Oncology & Andrology - Consultation open: G038 Dataset for penile and distal urethral cancer histopathology reports
The Royal College of Pathologists have invited BAUS Oncology and BAUS Andrology members to feedback on this dataset.
A pdf of the draft dataset can be found here (BAUS log-in required). Feedback should be sent by email to: The Royal College of Pathologists